33 Trending Stocks

Thu, Jan 21, 2021

Lipocine Inc

LPCN 2.07
0.31 (17.6%)

Open: 1.81 High: 2.15 Low: 1.69

9 x 2.07 = 18.63
x $2.07 =

NASDAQ: LPCN $110 Million Small-Cap. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 78%. 1 Year Return 291%. 2021 YTD Return 45%. Since Earnings 45%.

ST

External Links

Charts

image
image

52WL $0.32

The 52 Week Low is $0.32 set on Mon, Mar 16, 2020.

52WH $2.39

The 52 Week High is $2.39 set on Mon, Aug 17, 2020.

ATH $20.00

The All-Time High is $20.00 set on Wed, Aug 28, 2013.

52 Week Range

$0.32
$2.39
Mar 16, 2020
Aug 17, 2020

Earnings

-0.13

Earnings Per Share

0.00

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Thu, Aug 6, 2020

Since Q2 Earnings Report

LPCN 5.6%


Q3 Earnings for Jul, Aug & Sep

Tue, Nov 10, 2020

Since Q3 Earnings Report

LPCN 44.8%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Lipocine Inc trades on the NASDAQ. LPCN's market cap is 110.00 Million.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.